Shared Content

Blood Biomarkers for Early Alzheimer's, Jan 2024–May 2025

Content may be unverified or unsafe. Report

Citations

Blood Test for Alzheimer Disease Made Clinically Available and CLIA Certified - - PracticalNeurology

https://practicalneurology.com/news/blood-test-for-alzheimer-disease-made-clinically-available-and-clia-certified

Alzheimer’s Blood Tests Could Improve Diagnosis | alz.org

https://aaic.alz.org/releases-2024/blood-tests-alzheimers-biomarkers.asp

Alzheimer’s Blood Tests Could Improve Diagnosis | alz.org

https://aaic.alz.org/releases-2024/blood-tests-alzheimers-biomarkers.asp

Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community | Nature Medicine

https://www.nature.com/articles/s41591-025-03605-x

Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community | Nature Medicine

https://www.nature.com/articles/s41591-025-03605-x

Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care - PubMed

https://pubmed.ncbi.nlm.nih.gov/39068545/

Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care - PubMed

https://pubmed.ncbi.nlm.nih.gov/39068545/

Alzheimer’s Blood Tests Could Improve Diagnosis | alz.org

https://aaic.alz.org/releases-2024/blood-tests-alzheimers-biomarkers.asp

C2N Diagnostics’ PrecivityAD2™ Blood Test Receives MHRA Medical Device Certification in the United Kingdom — PrecivityAD®

https://precivityad.com/news/k1e196pn490zw2wogr6sublpkxndp4

C2N Diagnostics’ PrecivityAD2™ Blood Test Receives MHRA Medical Device Certification in the United Kingdom — PrecivityAD®

https://precivityad.com/news/k1e196pn490zw2wogr6sublpkxndp4

Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects | Communications Medicine

https://www.nature.com/articles/s43856-024-00690-w

Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects | Communications Medicine

https://www.nature.com/articles/s43856-024-00690-w

Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects | Communications Medicine

https://www.nature.com/articles/s43856-024-00690-w

Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects | Communications Medicine

https://www.nature.com/articles/s43856-024-00690-w

Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers - PMC

https://pmc.ncbi.nlm.nih.gov/articles/PMC11811866/

Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers - PMC

https://pmc.ncbi.nlm.nih.gov/articles/PMC11811866/

Detection of Alzheimer Neuropathology in Alzheimer and Non-Alzheimer Clinical Syndromes With Blood-Based Biomarkers - PMC

https://pmc.ncbi.nlm.nih.gov/articles/PMC11811866/

Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability | Nature Aging

https://www.nature.com/articles/s43587-024-00731-y

Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability | Nature Aging

https://www.nature.com/articles/s43587-024-00731-y

Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability | Nature Aging

https://www.nature.com/articles/s43587-024-00731-y

Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care - PubMed

https://pubmed.ncbi.nlm.nih.gov/39068545/

Study Probes Blood Biomarker for Early-stage Alzheimer's Disease < Yale School of Medicine

https://medicine.yale.edu/news-article/study-probes-blood-biomarker-for-early-stage-alzheimers-disease/

Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability | Nature Aging

https://www.nature.com/articles/s43587-024-00731-y

Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease | Nature Medicine

https://www.nature.com/articles/s41591-022-01925-w

Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease | Nature Medicine

https://www.nature.com/articles/s41591-022-01925-w

A new study identifies two biomarkers in the blood that better capture early signs of Alzheimer's | BBRC

https://www.barcelonabeta.org/en/news/news/new-study-identifies-two-biomarkers-blood-better-capture-early-signs-alzheimers

Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration - PubMed

https://pubmed.ncbi.nlm.nih.gov/36572122/

Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration - PubMed

https://pubmed.ncbi.nlm.nih.gov/36572122/

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease | Nature Communications

https://www.nature.com/articles/s41467-024-47286-5

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease | Nature Communications

https://www.nature.com/articles/s41467-024-47286-5

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease | Nature Communications

https://www.nature.com/articles/s41467-024-47286-5

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease | Nature Communications

https://www.nature.com/articles/s41467-024-47286-5

Blood biomarkers for clinical applications in Alzheimer's disease

https://www.sciencedirect.com/science/article/pii/S2950588725000436

Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community | Nature Medicine

https://www.nature.com/articles/s41591-025-03605-x

Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability | Nature Aging

https://www.nature.com/articles/s43587-024-00731-y

New biomarker tracks cognitive decline in Alzheimer’s disease | National Institutes of Health (NIH)

https://www.nih.gov/news-events/nih-research-matters/new-biomarker-tracks-cognitive-decline-alzheimer-s-disease

New biomarker tracks cognitive decline in Alzheimer’s disease | National Institutes of Health (NIH)

https://www.nih.gov/news-events/nih-research-matters/new-biomarker-tracks-cognitive-decline-alzheimer-s-disease

New biomarker tracks cognitive decline in Alzheimer’s disease | National Institutes of Health (NIH)

https://www.nih.gov/news-events/nih-research-matters/new-biomarker-tracks-cognitive-decline-alzheimer-s-disease

New biomarker tracks cognitive decline in Alzheimer’s disease | National Institutes of Health (NIH)

https://www.nih.gov/news-events/nih-research-matters/new-biomarker-tracks-cognitive-decline-alzheimer-s-disease

New biomarker tracks cognitive decline in Alzheimer’s disease | National Institutes of Health (NIH)

https://www.nih.gov/news-events/nih-research-matters/new-biomarker-tracks-cognitive-decline-alzheimer-s-disease

New biomarker tracks cognitive decline in Alzheimer’s disease | National Institutes of Health (NIH)

https://www.nih.gov/news-events/nih-research-matters/new-biomarker-tracks-cognitive-decline-alzheimer-s-disease

New biomarker tracks cognitive decline in Alzheimer’s disease | National Institutes of Health (NIH)

https://www.nih.gov/news-events/nih-research-matters/new-biomarker-tracks-cognitive-decline-alzheimer-s-disease

Blood Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-Analysis - PMC

https://pmc.ncbi.nlm.nih.gov/articles/PMC11314950/

Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community | Nature Medicine

https://www.nature.com/articles/s41591-025-03605-x

Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community | Nature Medicine

https://www.nature.com/articles/s41591-025-03605-x

Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability | Nature Aging

https://www.nature.com/articles/s43587-024-00731-y

Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability | Nature Aging

https://www.nature.com/articles/s43587-024-00731-y

Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability | Nature Aging

https://www.nature.com/articles/s43587-024-00731-y

Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community | Nature Medicine

https://www.nature.com/articles/s41591-025-03605-x

Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community | Nature Medicine

https://www.nature.com/articles/s41591-025-03605-x

Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community | Nature Medicine

https://www.nature.com/articles/s41591-025-03605-x

Astrocyte biomarker signatures of amyloid-β and tau pathologies in ...

https://www.nature.com/articles/s41380-022-01716-2

Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability | Nature Aging

https://www.nature.com/articles/s43587-024-00731-y

Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability | Nature Aging

https://www.nature.com/articles/s43587-024-00731-y

Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community | Nature Medicine

https://www.nature.com/articles/s41591-025-03605-x

Alzheimer’s Blood Tests Could Improve Diagnosis | alz.org

https://aaic.alz.org/releases-2024/blood-tests-alzheimers-biomarkers.asp

Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability | Nature Aging

https://www.nature.com/articles/s43587-024-00731-y

Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability | Nature Aging

https://www.nature.com/articles/s43587-024-00731-y

Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care - PubMed

https://pubmed.ncbi.nlm.nih.gov/39068545/

Eisai Presents Latest Analysis of Lecanemab's Effect on Biomarker ...

https://investors.biogen.com/news-releases/news-release-details/eisai-presents-latest-analysis-lecanemabs-effect-biomarker

Fluid biomarkers in the context of amyloid-targeting disease ...

https://www.sciencedirect.com/science/article/pii/S2666634024003350

Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care - PubMed

https://pubmed.ncbi.nlm.nih.gov/39068545/

Blood Test for Alzheimer Disease Made Clinically Available and CLIA Certified - - PracticalNeurology

https://practicalneurology.com/news/blood-test-for-alzheimer-disease-made-clinically-available-and-clia-certified

Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects | Communications Medicine

https://www.nature.com/articles/s43856-024-00690-w

Blood-based biomarkers of Alzheimer’s disease and incident dementia in the community | Nature Medicine

https://www.nature.com/articles/s41591-025-03605-x

All Sources